Stay updated on Somapacitan vs Placebo & Norditropin in GH Deficiency Clinical Trial
Sign up to get notified when there's something new on the Somapacitan vs Placebo & Norditropin in GH Deficiency Clinical Trial page.

Latest updates to the Somapacitan vs Placebo & Norditropin in GH Deficiency Clinical Trial page
- Check6 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0. The page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check20 days agoChange DetectedA site-wide NIH notice announces a website transition and explains that “Super Intelligence” may appear in place of “Artificial Intelligence.” The site revision number also changed.SummaryDifference1%

- Check34 days agoChange DetectedThe site's footer revision number was updated from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page now renders a 403 Forbidden error, blocking access to the study record content. Previously visible sponsor and study details are no longer accessible.SummaryDifference22%

- Check55 days agoChange DetectedRevision updated from v3.6.6 to v3.7.0, representing an update to the page's underlying software version.SummaryDifference0.0%

- Check62 days agoChange DetectedTel Litwinsky, Israel, 52621 was added as a participating site, replacing Qiryat Krinitzi, Israel, 52621 in the Locations section.SummaryDifference0.0%

Stay in the know with updates to Somapacitan vs Placebo & Norditropin in GH Deficiency Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Somapacitan vs Placebo & Norditropin in GH Deficiency Clinical Trial page.